XML 26 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Non- controlling Interests
Balance, beginning of period at Dec. 31, 2017 $ 2,857.6 $ 1.2 $ 3,302.6 $ 2,713.0 $ 15.3 $ (288.2) $ (15.3) $ (2,953.7) $ 82.7
Balance, beginning of period (in shares) at Dec. 31, 2017   116,303,729              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Net earnings $ 556.7     556.7          
Other comprehensive income (loss) (96.3)         (96.3)      
Issuances under equity plans (12.1)   5.2         (17.3)  
Issuances under equity plans (in shares)   492,170              
Share-based compensation expense 27.8   27.8            
Dividends (127.3)     (127.3)          
Repurchases of common stock (500.7)             (500.7)  
Noncontrolling interest transactions (7.2)   1.9           (9.1)
Balance, end of period at Dec. 31, 2018 2,698.5 $ 1.2 3,337.5 3,157.7   (399.8)   (3,471.7) 73.6
Balance, end of period (in shares) at Dec. 31, 2018   116,795,899              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 465.7     465.7          
Other comprehensive income (loss) (41.2)         (41.2)      
Issuances under equity plans (0.2)   7.0         (7.2)  
Issuances under equity plans (in shares)   394,984              
Share-based compensation expense 26.3   26.3            
Dividends (129.3)     (129.3)          
Repurchases of common stock (203.0)             (203.0)  
Noncontrolling interest transactions (55.3)   (0.2)           (55.1)
Balance, end of period at Dec. 31, 2019 2,761.5 $ 1.2 3,370.6 3,494.1   (441.0)   (3,681.9) 18.5
Balance, end of period (in shares) at Dec. 31, 2019   117,190,883              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net earnings 23.8     23.8          
Other comprehensive income (loss) 43.7         43.7      
Issuances under equity plans 0.1   7.7         (7.6)  
Issuances under equity plans (in shares)   365,108              
Share-based compensation expense 24.2   24.2            
Dividends (129.1)     (129.1)          
Repurchases of common stock (264.7)             (264.7)  
Noncontrolling interest transactions (5.9)               (5.9)
Balance, end of period at Dec. 31, 2020 $ 2,453.6 $ 1.2 $ 3,402.5 $ 3,388.8   $ (397.3)   $ (3,954.2) $ 12.6
Balance, end of period (in shares) at Dec. 31, 2020   117,555,991